AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05782218 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Coconut
Description: Participants will receive 1 oz (30 g) of a coconut-chocolate bar and 1.4 oz (40 g) of 100% dried coconut chips to ingest within 15 minutes.
Study NCT05934799 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Clopidogrel film-coated tablet 75 mg
Description: Clopidogrel is manufactured by Pharmtechnology LLC, Republic of Belarus. Each tablet contains 75 mg of clopidogrel.
Study NCT05934799 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Plavix® film-coated tablet 75 mg
Description: Plavix® is manufactured by Sanofi Winthrop Industry, France; holder RU: Sanofi-Aventis Group S.A., France. Each tablet contains 75 mg of clopidogrel.
Study NCT04801316 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Steady Feet exercise programme
Description: Steady Feet (SF) is a 6-month community-based structured exercise programme aimed at improving physical strength and balance among older adults (aged 60 years and above) who are at high risk of falls.~This exercise programme was developed by Changi General Hospital's physiotherapists and exercise physiologist from evidence found in the literature.
Study NCT04801316 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Steady Feet Video
Description: About an hour-long video showcasing the exercise steps of the Steady Feet exercise programme
Study NCT06424665 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FZ-AD005
Description: Every 21 days for 1 cycle. Subjects will receive an intravenous infusion of FZ-AD005 until confirmed progression, unaccepted toxicity, or any criterion for withdrawal from the study.
Study NCT06378658 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BAY2927088
Description: Oral administration
Study NCT06378658 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Esomeprazole
Description: Oral administration
Study NCT06378658 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Food
Description: light low-fat meal or high fat, high calorie meal
Study NCT05561010 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Intra-articular injection of bupivacaine in the knee joint
Description: 25 participants will be allocated to the bupivacaine arm.
Study NCT05561010 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Intra-articular injection of placebo in the knee joint
Description: 25 participants will be allocated to the placebo arm.
Study NCT04884776 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Microbiome immunity formula
Description: Microbiome immunity formula contains probiotics blend (3 Bifidobacteria, 10 billion CFU per sachet)
Study NCT04884776 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Active placebo
Description: Active placebo contains active vitamin
Study NCT05466708 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Esketamine combined with dexmedetomidine
Description: Esketamine, injection, 50mg/ bottle, source: hospital pharmacy, production unit: Jiangsu Hengrui Pharmaceutical Co., LTD., validity: 2 years, storage condition: airtight shading, room temperature.~Dexmedetomidine, injection, 0.2mg/ bottle, source: Hospital Pharmacy, manufacturer: Jiangsu Hengrui Pharmaceutical Co., LTD., expiration date: 18 months, storage condition: airtight shading, room temperature.
Study NCT05977361 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Resiting Epidural Catheter
Description: After a UDP has occurred, epidural catheter will be re-sited in a different intervertebral space. Analgesia will be then maintained according to internal protocol, using PIEB (Programmed Intermittent Epidural Bolus) system. Catheter will be left in place for the first 24-36 hours.
Study NCT05977361 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Intrathecal Catheter Placement
Description: After a UDP has occurred, an intrathecal catheter will be placed through the dural tap. Analgesia will be then maintained according to internal protocol, using PISB (Programmed Intermittent Subarachnoid Bolus) system. Catheter will be left in place for the first 24-36 hours. During this time, a continuous infusion of sterile saline at a rate of 2 mL/h will be maintained. Before removal, an additional bolus of 10 mL of sterile saline will be administered in the intrathecal catheter.
Study NCT05466708 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexmedetomidine
Description: Dexmedetomidine, injection, 0.2mg/ bottle, source: Hospital Pharmacy, manufacturer: Jiangsu Hengrui Pharmaceutical Co., LTD., expiration date: 18 months, storage condition: airtight shading, room temperature.
Study NCT05551962 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Soft tissue augmentation with CTG
Description: 1. Incision the mucosa at the alveolar ridge, mucosal-periosteal flap elevation~2. Placement of the Astra Tech dental implant (Dentsply, Germany)~3. Sampling of free connective tissue graft from the maxilla tuber area~4. Fixation of the graft to the vestibular flap~5. Suturing the wound tightly
Study NCT05373771 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Care pathway
Description: Implementation of care pathway as part of hybrid type 2 implementation effectiveness study
Study NCT05551962 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Soft tissue augmentation with CM
Description: 1. Incision the mucosa at the alveolar ridge, mucosal-periosteal flap elevation~2. Placement of the Astra Tech dental implant (Dentsply, Germany)~3. Modeling of sterile collagen matrix according to the shape of the recipient bed~4. Fixation of the collagen matrix to the vestibular flap~5. Suturing the wound tightly
Study NCT05187884 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Darovasertib
Description: Oral Darovasertib 300 mg tablets twice daily
Study NCT05086913 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Lifestyle medicine smartphone booklets
Description: Participants will receive a pocket size 6-page booklet weekly over 8 weeks that covers 8 lifestyle medicine, mental health and CBT themes including stress, relaxation, diet, exercise, sleep hygiene, worry management, mindfulness, and positive psychology, and guides participants to set and meet short term and long-term goals.
Study NCT05086913 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Lifestyle medicine smartphone app
Description: The lifestyle medicine app offers 8 modules with identical content as the wellness booklets, in addition to videos, relaxation, exercise and cooking demonstrations, daily challenges, record of goals, and ecological momentary assessments of diet, physical activity, sleep, stress and mood.
Study NCT05086913 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Waitlist control
Description: The waitlist control group will receive access to the lifestyle medicine app and booklets at the end of the study.
Study NCT06207253 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Diclofenac Sodium
Description: placement of intracanal medication for the three groups will be done after cleaning and shaping of the root canals and it will be left for one week.
Study NCT06207253 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Diclofenac Sodium
Description: placement of intracanal medication for the three groups will be done after cleaning and shaping of the root canals and it will be left for one week.
Study NCT06207253 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Calcium hydroxide
Description: placement of intracanal medication for the three groups will be done after cleaning and shaping of the root canals and it will be left for one week.
Study NCT05110547 — intervention group
Intervention type: BIOLOGICAL
Intervention: blood collection
Description: 2 additional 5ml EDTA tubes, with assays for the following markers: 24S and 27 hydroxycholesterol (gas chromatography-mass spectrometry, GC-MS), Neurofilaments (SIMOA), oxydative phosphorylation (OXPHOS) and quantitative measurement of intracellular ATP (ELISA), Very long chain fatty acids (GC-MS), Octanoyl CoA (HPLC), Uric acid, MDA assay (TBAR assay kit), and Lipid panel.
Study NCT05184296 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Extracorporeal Membrane Oxygenation (ECMO)
Description: All patients in cohort 1 will initiate ECMO as fast as possible. A maximum of 6 hours is allowed between enrollment and the actual initiation of ECMO. ECMO catheterization and management will be operated by an experienced ECMO team and carried out at the bedside. VA or VAV mode will be chosen according to the patient's condition.
Study NCT05612295 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Self-talk
Description: self-talk sessions include: Session 1 \& 2. The concepts, types, and the importance of self-talk will be introduced; Session 3. Researchers, coaches and the athletes will work together to design syntactically recognizable, concise, and clear sport-specific instructional scripts for specific sports performance (e.g., running); Session 4. practice of sport-specific instructional self-talk; Session 5. researchers, coaches and the athletes will work together to design syntactically recognizable, concise, and clear sport-specific motivational self-talk scripts for specific sports performances; Session 6. practice of sport-specific motivational self-talk; and Session 7 \& 8. general practice for learned self-talk techniques.
Study NCT06447493 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Osteopathic Manipulative Treatment-Spencer's Technique (Modified)
Description: Combination OMT approach utilizing Muscle Energy Technique (MET), Articulatory Technique (ART), and Myofascial Release (MFR). It is a series of direct OMT addressing the barrier of somatic dysfunction (SD) with the goal of restoring neurovascular balance and improved motion of the shoulder girdle and glenohumeral joint. Utilizing these three OMT techniques, the practitioner attempts restoration of glenohumeral joint motion using shoulder extension, flexion, circumduction with compression, circumduction with distraction, abduction, adduction, external rotation, internal rotation, and distraction in abduction. The study uses a modified version of the Spencer technique, done in the seated position for patient comfort, as well as adding to the treatment sequence: latissimus dorsi, pectoralis minor-major, serratus anterior, and rhomboid major-minor. Adding these muscles into treatment will help to address and correct sternoclavicular joint SD, acromioclavicular joint SD, and scapular SD.
Study NCT04917510 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Erector spinae block
Description: See experimental arm group description
Study NCT06447493 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rest
Description: 10 minute rest period.
Study NCT06007859 — intervention group
Intervention type: OTHER
Intervention: section orientation
Description: The patient was placed in a decubitus supine head back extension position to fully expose the cervical thyroid examination site. The instrument was adjusted appropriately to achieve optimal imaging quality, the suspicious nodule was located in conventional ultrasound mode, the SWE option in VT mode was selected, and the patient was instructed to hold his/her breath to minimize the effect of respiration, and elastograms of the nodule in transverse and longitudinal sections were obtained.
Study NCT05719636 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional treatment
Description: Conventional protocol that involves simple active and passive range of motion exercises of lower limb with positioning for assistive devices was provided
Study NCT05719636 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Progressive resistance exercise
Description: The protocol that was applied on the members of (experimental group) are progressive resistance exercises. These passive resistance exercises included Flexion, Extension, Abduction, Adduction of hip; Flexion, Extension of knee; with minimum time in start and minimum quantity of loads, with Thera bands and sandbags,.
Study NCT01269398 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: GO-LIF and SpineAssist SYSTEMS
Study NCT04917510 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Local block
Description: See control and study arm group descriptions for the local block
Study NCT04917510 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Local block
Description: See control and study arm group descriptions for the local block
Study NCT05005559 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant
Description: SARS-CoV-2 recombinant spike protein (25 µg) with Advax-SM adjuvant (15 mg) in two doses with a 21-day interval administered with intramuscular injections in the deltoid muscle of the non-dominant arm
Study NCT05005559 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Saline placebo
Description: 0.9% sodium chloride (1 mL) injection in two doses with a 21-day interval administered with intramuscular injections in the deltoid muscle of the non-dominant arm
Study NCT05065944 — intervention group
Intervention type: BEHAVIORAL
Intervention: Telemedicine
Description: Pre-anesthesia assessment (history and physical examination) via telemedicine. Intervention is a one-time telemedicine clinic visit for approximately 30 minutes to 1 hour. Individual patients will be randomized to telemedicine and that visit will be scheduled via the Zoom video conferencing platform.
Study NCT05065944 — intervention group
Intervention type: BEHAVIORAL
Intervention: In Person Visit
Description: Pre-anesthesia assessment (history and physical examination) in person at Moffitt Cancer Center (usual care)
Study NCT04897412 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CBL-514 Injection
Description: Formulated as an injectable CBL-514 solution at a concentration of 5 mg/mL.
Study NCT04897412 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Sodium Chloride (0.9% NaCl) placebo for injection
Study NCT04728971 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Micafungin Sodium 50 MG Injection
Description: Give Micafungin 150 mg/d within 24 hours after liver transplantation.
Study NCT04728971 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Caspofungin Acetate
Description: Give Caspofungin 35 mg/d lasts 1 week after liver transplantation.
Study NCT05832424 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: UPLIFT program
Description: The telehealth group intervention will be delivered using Zoom. Participants will attend facilitated weekly, 1-hour sessions for 8 weeks. The sessions follow a standardized, manualized program based on cognitive-behavioral therapy (CBT) and mindfulness-based practice (MBP)-therapies widely accepted and used by mental health providers for the treatment and prevention of depression and substance use. The study team have tailored this intervention for use in a pregnant population.
Study NCT06472895 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AK112 monotherapy
Description: A novel PD-1/VEGF bispecific antibody; RP2D intravenously (IV)，Q3W
Study NCT05399758 — intervention group
Intervention type: DEVICE
Intervention: NOL monitor
Description: NOL monitor data will be acquired, as well as clinical assessment of pain and fentanyl dosage.
Study NCT04760314 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lebrikizumab
Description: Administered SC
Study NCT04760314 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administered SC
Study NCT04760314 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Topical Corticosteroid
Description: Self-applied
Study NCT04760314 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Topical Corticosteroid
Description: Self-applied
Study NCT05781750 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: zetomipzomib
Description: Subcutaneous injection of zetomipzomib
Study NCT04707963 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Peanut protein powder
Description: Peanut protein powder will be provided to participants who will be instructed to consume 72g daily, mixed with water
Study NCT04707963 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Full body resistance training
Description: Participants will undergo supervised resistance training two times per week (5 exercises, 3 sets of 8-12 repetitions per set)
Study NCT04707963 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Full body resistance training
Description: Participants will undergo supervised resistance training two times per week (5 exercises, 3 sets of 8-12 repetitions per set)
Study NCT06000579 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EFT
Description: Each student will be asked to voluntarily give their phone number and last menstrual cycle date, and the day will be determined for the first session. Then, the first EFT session will be made by the researchers by calling 14 days before the menstruation date. In the 2nd and 3rd sessions, a total of 3 sessions of EFT will be applied face-to-face by the researchers 14 days before menstruation. After each student completes three menstrual cycles, the researchers will meet with the student and PMSS will be applied as a post-test.
Study NCT05781750 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: Subcutaneous injection of placebo
Study NCT06521593 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Applying a tourniquet for either a short or long time during total knee replacement
Description: All patients underwent spinal anesthesia and the tourniquet was applied to the middle of the thigh; in group one who underwent long-duration application of a tourniquet, it was applied only before the skin incision by inflating it to 150 mmHg above the systolic blood pressure of the patients and deflation finishing of bone cementation while in group two who underwent short duration application of a tourniquet, the tourniquet was only applied just before cementation, was inflated also to 150 mmHg above the systolic blood pressure of the patients, and was deflated after bone cementation.
Study NCT06521593 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Applying a tourniquet for either a short or long time during total knee replacement
Description: All patients underwent spinal anesthesia and the tourniquet was applied to the middle of the thigh; in group one who underwent long-duration application of a tourniquet, it was applied only before the skin incision by inflating it to 150 mmHg above the systolic blood pressure of the patients and deflation finishing of bone cementation while in group two who underwent short duration application of a tourniquet, the tourniquet was only applied just before cementation, was inflated also to 150 mmHg above the systolic blood pressure of the patients, and was deflated after bone cementation.
Study NCT04709757 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Intermittent Dosing HF10 30/90
Description: 10kHz frequency spinal cord stimulation delivered at 30 seconds ON and 120 seconds OFF
Study NCT04709757 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Intermittent Dosing HF10 30/360
Description: 10kHz frequency spinal cord stimulation delivered at 30 seconds ON and 360 seconds OFF
Study NCT05497557 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Omeprazole
Description: Omeprazole will be administered as an oral capsule.
Study NCT04991597 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cold Compress Pack
Description: Palmar aspect of forearm will have a cold compress pack placed on it.
Study NCT05347589 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Post isometric relaxation of quadratus lumborum and gluteus Gluteus maximus activation exercises
Description: Post Isometric Relaxation: The patient will be in a left recumbent position with his leg in a fully flexed position close to his chest and fixed by his left hand. The patient is asked to hold the treatment table with a right hand in an overhead position to support the body in applying the technique. The patient fully extended left will be taken away from the treatment table. At this point, the patient will be asked to press the leg down until the range where the patient feels discomfort to the point of torsion of Quadratus lumborum. This is the point that is the barrier range. Smaller than this range the patient will be asked to lift his left against the counterforce by the therapist and hold it for five to seven seconds which will be followed by five to seven seconds of relaxation. The technique will be repeated by five times in the pain-free range.
Study NCT05347589 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: post isometric relaxation of the Quadratus lumborum
Description: Post Isometric Relaxation: The patient will be in a left recumbent position with his leg in a fully flexed position close to his chest and fixed by his left hand. The patient is asked to hold the treatment table with a right hand in an overhead position to support the body in applying the technique. The patient fully extended left will be taken away from the treatment table. At this point, the patient will be asked to press the leg down until the range where the patient feels discomfort to the point of torsion of Quadratus lumborum. This is the point that is the barrier range. Smaller than this range the patient will be asked to lift his left against the counterforce by the therapist and hold it for five to seven seconds which will be followed by five to seven seconds of relaxation. The technique will be repeated by five times in the pain-free range
Study NCT04991597 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Room Temperature Compress Pack
Description: Palmar aspect of forearm will have a room temperature compress pack placed on it.